Main Street Research LLC Acquires New Stake in SPDR S&P Biotech ETF $XBI

Main Street Research LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 360,526 shares of the exchange traded fund’s stock, valued at approximately $43,959,000. SPDR S&P Biotech ETF accounts for approximately 2.5% of Main Street Research LLC’s holdings, making the stock its 17th largest position. Main Street Research LLC owned approximately 0.54% of SPDR S&P Biotech ETF as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in XBI. AQR Capital Management LLC boosted its stake in SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares during the period. Marshall Wace LLP boosted its stake in SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after buying an additional 179,029 shares during the period. The Manufacturers Life Insurance Company bought a new stake in SPDR S&P Biotech ETF during the second quarter valued at $260,000. Ameriprise Financial Inc. boosted its stake in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after buying an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $131.66 on Monday. The firm has a market capitalization of $8.40 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52-week low of $78.00 and a 52-week high of $139.19. The stock has a fifty day moving average of $129.82 and a 200 day moving average of $125.16.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.